相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural Characterization of a Monoclonal Antibody-Maytansinoid Immunoconjugate
Quanzhou Luo et al.
ANALYTICAL CHEMISTRY (2016)
Challenges and advances in the assessment of the disposition of antibody-drug conjugates
Amrita V. Kamath et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2016)
Kinase inhibitors and monoclonal antibodies in oncology: clinical implications
Helen Gharwan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Antibody-drug conjugates-an emerging class of cancer treatment
Nikolaos Diamantis et al.
BRITISH JOURNAL OF CANCER (2016)
New developments for antibody-drug conjugate-based therapeutic approaches
Bart E. C. G. de Goeij et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Current Status: Site-Specific Antibody Drug Conjugates
Dominik Schumacher et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2016)
Physical and Chemical Stability of Antibody Drug Conjugates: Current Status
Philip L. Ross et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Immunogenicity of Therapeutic Protein Aggregates
Ehab M. Moussa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
Heather Donaghy
MABS (2016)
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper
Eugenia Kraynov et al.
DRUG METABOLISM AND DISPOSITION (2016)
Antibody Drug Conjugates for Cancer Therapy
Paul Polakis
PHARMACOLOGICAL REVIEWS (2016)
Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
Jessica R. McCombs et al.
AAPS JOURNAL (2015)
Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids
Gregory S. Hamilton
BIOLOGICALS (2015)
Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
Eunhee G. Kim et al.
BIOMOLECULES & THERAPEUTICS (2015)
Antibody-targeted drugs and drug resistance-Challenges and solutions
LeeRon Shefet-Carasso et al.
DRUG RESISTANCE UPDATES (2015)
Trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
Tom Van den Mooter et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Emerging formats for next-generation antibody drug conjugates
Mahendra P. Deonarain et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Quantitative bioanalysis of antibody-conjugated payload in monkey plasma using a hybrid immuno-capture LC-MS/MS approach: Assay development, validation, and a case study
Ang Liu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
Beyond Peptides and mAbs-Current Status and Future Perspectives for Biotherapeutics With Novel Constructs
Dalal AlDeghaither et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Iftikhar Ali Khawar et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
Liming Liu
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Recent Advances in the Development of New Auristatins: Structural Modifications and Application in Antibody Drug Conjugates
Andreas Maderna et al.
MOLECULAR PHARMACEUTICS (2015)
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading
Pavel Strop et al.
NATURE BIOTECHNOLOGY (2015)
Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability
Satish K. Singh et al.
PHARMACEUTICAL RESEARCH (2015)
Current ADC Linker Chemistry
Nareshkumar Jain et al.
PHARMACEUTICAL RESEARCH (2015)
Immunogenicity of Antibody Drug Conjugates: Bioanalytical Methods and Monitoring Strategy for a Novel Therapeutic Modality
M. Benjamin Hock et al.
AAPS JOURNAL (2015)
Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates
Dowdy Jackson et al.
PHARMACEUTICAL RESEARCH (2015)
Methods to Make Homogenous Antibody Drug Conjugates
Toni Kline et al.
PHARMACEUTICAL RESEARCH (2015)
Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
Franco Dosio et al.
Recent Patents on Anti-Cancer Drug Discovery (2015)
Antibody- Drug Conjugates: An Emerging Concept in Cancer Therapy
Ravi V. J. Chari et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload
Yilma T. Adem et al.
BIOCONJUGATE CHEMISTRY (2014)
Trastuzumab emtansine: mechanisms of action and drug resistance
Mark Barok et al.
BREAST CANCER RESEARCH (2014)
Antibody-drug conjugates: current status and future directions
Heidi L. Perez et al.
DRUG DISCOVERY TODAY (2014)
Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy
Sohita Dhillon
DRUGS (2014)
Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept-Targeted Drug Delivery with Antibody-Drug Conjugates for Cancers
Rodney J. Y. Ho et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Methods for site-specific drug conjugation to antibodies
Christopher R. Behrens et al.
MABS (2014)
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Vladimir P. Torchilin
NATURE REVIEWS DRUG DISCOVERY (2014)
The Next Generation of Antibody Drug Conjugates
Fiona Mack et al.
SEMINARS IN ONCOLOGY (2014)
Comparison of Drug Approvals in Europe Versus the United States: An Analysis of Discrepancies Between Drug Products Reviewed by EMA and FDA
Robert W. Makuch et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Antibody-Drug Conjugates in Cancer Therapy
Eric L. Sievers et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Investigation into Temperature-Induced Aggregation of an Antibody Drug Conjugate
Nia S. Beckley et al.
BIOCONJUGATE CHEMISTRY (2013)
Drug-conjugated antibodies for the treatment of cancer
John M. Lambert
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
General overview of radioimmunotherapy of solid tumors
Isabelle Navarro-Teulon et al.
IMMUNOTHERAPY (2013)
Antibody Therapeutics in Cancer
Mark X. Sliwkowski et al.
SCIENCE (2013)
Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Sean L. Kitson et al.
CURRENT RADIOPHARMACEUTICALS (2013)
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Twan Lammers et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
P. Mark Hogarth et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Analytical methods for physicochemical characterization of antibody drug conjugates
Aditya Wakankar et al.
MABS (2011)
Self-immolative linkers in polymeric delivery systems
Christopher A. Blencowe et al.
POLYMER CHEMISTRY (2011)
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Johanna Chiche et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Stability of IgG isotypes in serum
Ivan R. Correia
MABS (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Targeted cancer therapy: Conferring specificity to cytotoxic drugs
Ravi V. J. Chari
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange
Marijn van der Neut Kolfschoten et al.
SCIENCE (2007)
Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment
Charlotte F. McDonagh et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
Pharmacokinetic aspects of biotechnology products
L Tang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
KJ Hamblett et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
